You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
|
|---|---|
| Published in |
PharmacoEconomics, December 2012
|
| DOI | 10.2165/11595340-000000000-00000 |
| Pubmed ID | |
| Authors |
Christopher Fitzpatrick, Katherine Floyd |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 235 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| United Kingdom | 2 | <1% |
| Switzerland | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Brazil | 1 | <1% |
| Sweden | 1 | <1% |
| Malaysia | 1 | <1% |
| India | 1 | <1% |
| Chile | 1 | <1% |
| Other | 2 | <1% |
| Unknown | 221 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 50 | 21% |
| Researcher | 48 | 20% |
| Student > Ph. D. Student | 26 | 11% |
| Other | 18 | 8% |
| Student > Bachelor | 14 | 6% |
| Other | 35 | 15% |
| Unknown | 44 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 86 | 37% |
| Agricultural and Biological Sciences | 17 | 7% |
| Social Sciences | 17 | 7% |
| Nursing and Health Professions | 15 | 6% |
| Business, Management and Accounting | 11 | 5% |
| Other | 36 | 15% |
| Unknown | 53 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2022.
All research outputs
#3,415,510
of 25,374,917 outputs
Outputs from PharmacoEconomics
#322
of 1,992 outputs
Outputs of similar age
#33,066
of 289,049 outputs
Outputs of similar age from PharmacoEconomics
#21
of 271 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,049 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 271 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.